Source: JDSupra —
While traditional office and retail properties have come under pressure from work-from-home and social distancing measures imposed during the COVID-19 pandemic, life sciences real estate has thrived. Moreover, given an aging population and a growing need for medical innovations, investors’ demand for life sciences real estate should continue unabated for the foreseeable future.
As a result, lenders have taken notice and are actively seeking to lend in this space. Financing life sciences real estate can be more challenging than lending on other asset classes, however. Life sciences real estate is not simply repurposed office space, and lenders must understand myriad unique issues that are not present in a typical real estate loan.
;
